Besides LMP1, we failed to detect EBERs transcripts in all the studied biopsies, which is consistent with previous reports.[23], [36], [37], [38] This data implies that EBERs in situ hybridization, which is considered the gold standard method to detect EBV in EBV-associated lymphoid malignancies, is not a suitable method to apply in breast carcinoma. The gene discussed is PDLIM7; the disease is breast carcinoma.